Total Funding
71
31
Total FundingDebt Financing raised
Growth Score
-4 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
467651
Smisson-Cartledge Biomedical is a medical device company developing therapeutic solutions for the treatment of thermal infusion care.
David C. Field: Chief Executive Officer- Hugh F. Smisson: Co-Founder and Board Chairman
About the Company
Smisson-Cartledge Biomedical, LLC, a medical device company, develops therapeutic solutions for the treatment of thermal infusion care. It offers ThermaCor 1200 infusion system, a portable infusion system that is used in a range of medical procedures, such as hypothermia patients, resuscitation, cardiac surgery, transplant surgery, post surgical
care, thoracic surgery, major aortic aneurysms, plastic surgery, irrigation, urological procedures, and cancer treatment. The company also develops compact in-line air trap/elimination systems. It offers its products in United States and the Kingdom of Saudi Arabia. Smisson-Cartledge Biomedical, LLC was founded in 1996 and is based in Macon, Georgia.
